GEBZIAS Trademark

Trademark Overview


On Thursday, August 29, 2019, a trademark application was filed for GEBZIAS with the United States Patent and Trademark Office. The USPTO has given the GEBZIAS trademark a serial number of 88597718. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2023. This trademark is owned by Eli Lilly and Company. The GEBZIAS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis
gebzias

General Information


Serial Number88597718
Word MarkGEBZIAS
Filing DateThursday, August 29, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, March 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 18, 2022SOU EXTENSION 5 GRANTED
Thursday, July 14, 2022SOU EXTENSION 5 FILED
Thursday, July 14, 2022SOU TEAS EXTENSION RECEIVED
Friday, January 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 13, 2022SOU EXTENSION 4 GRANTED
Tuesday, January 11, 2022SOU EXTENSION 4 FILED
Tuesday, January 11, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 16, 2021SOU EXTENSION 3 GRANTED
Friday, July 16, 2021SOU EXTENSION 3 FILED
Friday, July 16, 2021SOU TEAS EXTENSION RECEIVED
Friday, January 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 13, 2021SOU EXTENSION 2 GRANTED
Wednesday, January 13, 2021SOU EXTENSION 2 FILED
Wednesday, January 13, 2021SOU TEAS EXTENSION RECEIVED
Saturday, August 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 7, 2020SOU EXTENSION 1 GRANTED
Friday, July 10, 2020SOU EXTENSION 1 FILED
Thursday, August 6, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 10, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, February 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, November 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 26, 2019ASSIGNED TO EXAMINER
Wednesday, September 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 2, 2019NEW APPLICATION ENTERED